Follow
Edit
Upgrade- Company
SR Score
34,892
SR Web
36,511
KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).
Acquired by Merck & Co., Inc. on October 10, 2017
Website: https://www.kalvista.com
Founded: January 01, 2011
Social:
SR Traffic - Month
KalVista Pharmaceuticals Competitors
Add Competitor| Startup | Industry | Description |
|---|---|---|
|
Healthcare Equipment & Services | Read about the lives of diabetics. - Read about the lives of diabetics, find diabetic f ... |
|
Healthcare Equipment & Services | Daily Medication Log and Calendar - MedManage is a medication history, and calendar lo ... |
|
Healthcare Equipment & Services | Treating Acne Was never this Easy - MDAlgorithms developed a Mobile App platform to di ... |
KalVista Pharmaceuticals Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Jun 15, 2016 |
|
Undisclosed amount |
KalVista Pharmaceuticals Team
Add Team Member| Person | Role | Period |
|---|---|---|
|
Founder | Unknown to Unknown |
|
Founder | Unknown to Unknown |
|
Founder | Unknown to Unknown |
